Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02147834 · ClinicalTrials.gov registry record · Phase 2
Effectiveness of Ranolazine on Reducing Chest Pain in Patients With Blockage But no Stents
A Phase 2 study, sponsored by North Florida Foundation for Research and Education.
- Terminated
- Registry status
- Phase 2
- Development phase
- 5
- Enrollment target
NCT02147834 is a Phase 2 study that was terminated before completion, run by North Florida Foundation for Research and Education. The registered enrollment target is 5 participants.
The verdict
NCT02147834, a Phase 2 study, was terminated before completion, sponsored by North Florida Foundation for Research and Education.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 5 participants
- Enrollment target
Study Summary
To determine if ranolazine improves angina symptoms at 4 months compared with placebo among patients who are deferred for receiving a Percutaneous Coronary Intervention (PCI) based on the Fractional Flow Reserve (FFR) measurement.
Interventions
- DRUG Ranolazine
- DRUG Sugar pill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2015-08 |
| Est. Completion | 2016-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02147834
The ClinicalTrials.gov registry entry for NCT02147834 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is North Florida Foundation for Research and Education, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ranolazine is the first listed.
NCT02147834 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02147834 about?
NCT02147834 is a clinical study titled "Effectiveness of Ranolazine on Reducing Chest Pain in Patients With Blockage But no Stents". To determine if ranolazine improves angina symptoms at 4 months compared with placebo among patients who are deferred for receiving a Percutaneous Coronary Intervention (PCI) based on the Fractional Flow Reserve (FFR) measurement.
What is the current status of trial NCT02147834?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 5 participants. The study started on 2015-08. Estimated completion is 2016-09.
What interventions are being tested in trial NCT02147834?
The interventions under investigation include: Ranolazine (DRUG), Sugar pill (DRUG).
Who is sponsoring clinical trial NCT02147834?
This trial is sponsored by North Florida Foundation for Research and Education, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.